KYTX (Kyverna Therapeutics) FCF Yield % : -136.10 (As of Apr. 05, 2025)

View and export this data going back to 2024. Start your Free Trial

What is Kyverna Therapeutics FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Kyverna Therapeutics's Trailing 12-Month Free Cash Flow is $-116.46 Mil, and Market Cap is $85.57 Mil. Therefore, Kyverna Therapeutics's FCF Yield % for today is -136.10%.

The historical rank and industry rank for Kyverna Therapeutics's FCF Yield % or its related term are showing as below:

KYTX' s FCF Yield % Range Over the Past 10 Years
Min: -138.2 Med: -15.61 Max: -3.5
Current: -136.1

During the past 4 years, the highest FCF Yield % of Kyverna Therapeutics was -3.50%. The lowest was -138.20%. And the median was -15.61%.

KYTX's FCF Yield % is ranked worse than
86.31% of 1497 companies
in the Biotechnology industry
Industry Median: -15.53 vs KYTX: -136.10

Kyverna Therapeutics's FCF Margin % for the quarter that ended in Dec. 2024 was 0.00%.

Kyverna Therapeutics FCF Yield % Historical Data

The historical data trend for Kyverna Therapeutics's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kyverna Therapeutics FCF Yield % Chart

Kyverna Therapeutics Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

FCF Yield %

-72.05

Kyverna Therapeutics Quarterly Data
	Dec21	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
FCF Yield %	Get a 7-Day Free Trial						-	-9.74	-31.15	-52.28	-93.04

Competitive Comparison of Kyverna Therapeutics's FCF Yield %

For the Biotechnology subindustry, Kyverna Therapeutics's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kyverna Therapeutics's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Kyverna Therapeutics's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Kyverna Therapeutics's FCF Yield % falls into.

Save Embed

;

Save Embed

;

Kyverna Therapeutics FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Kyverna Therapeutics's FCF Yield % for the fiscal year that ended in Dec. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-116.455	/	161.6241
	=	-72.05%

Kyverna Therapeutics's annualized FCF Yield % for the quarter that ended in Dec. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-37.593	*	4	/	161.6241
	=	-93.04%

Kyverna Therapeutics FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Kyverna Therapeutics FCF Yield % Related Terms

Thank you for viewing the detailed overview of Kyverna Therapeutics's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Kyverna Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kyverna Therapeutics Inc (NAS:KYTX) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

5980 Horton Street, Suite 550, Emeryville, CA, USA, 94608

Website

https://www.kyvernatx.com

Kyverna Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on developing cell therapies for patients suffering from autoimmune diseases. Its product KYV-101, is an autologous CD19 CAR T-cell product candidate made from an underlying chimeric antigen receptor, or CAR. It is also developing KYV-201, an allogeneic therapy containing the same CAR as KYV-101, to develop it in multiple autoimmune diseases.